IQVIA Holdings Inc.

IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services to clients around the world. The company offers a range of information and laboratory services to the life sciences sector. Founded in 1982, IQVIA Holdings has its headquarters in Durham, North Carolina. Formerly known as Quintiles IMS Holdings, Inc., the company changed its name to IQVIA Holdings Inc. in November 2017. IQVIA operates its business through three segments, including Research & Development Solutions, Commercial Solutions, and Integrated Engagement Services. The Research & Development Solutions segment handles biopharmaceutical development services, including clinical monitoring and project management, virtual trials, clinical trial support services, and strategic planning and design services. This segment also offers a range of laboratory services, including vaccine and biomarker, genomic, bioanalytical, ADME, and discovery. IQVIA's Commercial Solutions segment provides technology solutions, national information offerings, sub-national information offerings, and workflow analytics and consulting services. The Integrated Engagement Services segment handles healthcare provider and patient engagement services, as well as medical affairs and scientific strategy services. IQVIA stock is listed on the NYSE under the ticker IQV. As of November 2021, the company employs approximately 77,000 workers and conducts operations in more than 100 countries. IQVIA maintains operations in Europe, Africa, the Americas, and the Asia-Pacific. The company has a strategic collaboration with HealthCore, Inc. Get the latest news and IQV share price updates by adding it to your eToro virtual portfolio.